img

Global Guillain-Barre Syndrome Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Guillain-Barre Syndrome Treatment Market Research Report 2024

According to MRAResearch’s new survey, global Guillain-Barre Syndrome Treatment market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Guillain-Barre Syndrome Treatment market research.
Key companies engaged in the Guillain-Barre Syndrome Treatment industry include CSL Limited, Grifols S A, Octapharma AG, Kedrion Biopharma Inc and Biotest AG, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Guillain-Barre Syndrome Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Guillain-Barre Syndrome Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Guillain-Barre Syndrome Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


CSL Limited
Grifols S A
Octapharma AG
Kedrion Biopharma Inc
Biotest AG
Segment by Type
Immunoglobulin Therapy
Plasma Exchange (Plasmapheresis)

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Guillain-Barre Syndrome Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Immunoglobulin Therapy
1.2.3 Plasma Exchange (Plasmapheresis)
1.3 Market by Application
1.3.1 Global Guillain-Barre Syndrome Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Guillain-Barre Syndrome Treatment Market Perspective (2018-2033)
2.2 Guillain-Barre Syndrome Treatment Growth Trends by Region
2.2.1 Global Guillain-Barre Syndrome Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Guillain-Barre Syndrome Treatment Historic Market Size by Region (2018-2023)
2.2.3 Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2024-2033)
2.3 Guillain-Barre Syndrome Treatment Market Dynamics
2.3.1 Guillain-Barre Syndrome Treatment Industry Trends
2.3.2 Guillain-Barre Syndrome Treatment Market Drivers
2.3.3 Guillain-Barre Syndrome Treatment Market Challenges
2.3.4 Guillain-Barre Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue
3.1.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue (2018-2023)
3.1.2 Global Guillain-Barre Syndrome Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Guillain-Barre Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barre Syndrome Treatment Revenue
3.4 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio
3.4.1 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barre Syndrome Treatment Revenue in 2022
3.5 Guillain-Barre Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Guillain-Barre Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guillain-Barre Syndrome Treatment Breakdown Data by Type
4.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Type (2018-2023)
4.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2024-2033)
5 Guillain-Barre Syndrome Treatment Breakdown Data by Application
5.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Application (2018-2023)
5.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Guillain-Barre Syndrome Treatment Market Size (2018-2033)
6.2 North America Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
6.4 North America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Guillain-Barre Syndrome Treatment Market Size (2018-2033)
7.2 Europe Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
7.4 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size (2018-2033)
8.2 Asia-Pacific Guillain-Barre Syndrome Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Guillain-Barre Syndrome Treatment Market Size (2018-2033)
9.2 Latin America Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
9.4 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size (2018-2033)
10.2 Middle East & Africa Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Limited
11.1.1 CSL Limited Company Detail
11.1.2 CSL Limited Business Overview
11.1.3 CSL Limited Guillain-Barre Syndrome Treatment Introduction
11.1.4 CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.1.5 CSL Limited Recent Development
11.2 Grifols S A
11.2.1 Grifols S A Company Detail
11.2.2 Grifols S A Business Overview
11.2.3 Grifols S A Guillain-Barre Syndrome Treatment Introduction
11.2.4 Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.2.5 Grifols S A Recent Development
11.3 Octapharma AG
11.3.1 Octapharma AG Company Detail
11.3.2 Octapharma AG Business Overview
11.3.3 Octapharma AG Guillain-Barre Syndrome Treatment Introduction
11.3.4 Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.3.5 Octapharma AG Recent Development
11.4 Kedrion Biopharma Inc
11.4.1 Kedrion Biopharma Inc Company Detail
11.4.2 Kedrion Biopharma Inc Business Overview
11.4.3 Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Introduction
11.4.4 Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.4.5 Kedrion Biopharma Inc Recent Development
11.5 Biotest AG
11.5.1 Biotest AG Company Detail
11.5.2 Biotest AG Business Overview
11.5.3 Biotest AG Guillain-Barre Syndrome Treatment Introduction
11.5.4 Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.5.5 Biotest AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Immunoglobulin Therapy
Table 3. Key Players of Plasma Exchange (Plasmapheresis)
Table 4. Global Guillain-Barre Syndrome Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Guillain-Barre Syndrome Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Guillain-Barre Syndrome Treatment Market Share by Region (2018-2023)
Table 8. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Guillain-Barre Syndrome Treatment Market Share by Region (2024-2033)
Table 10. Guillain-Barre Syndrome Treatment Market Trends
Table 11. Guillain-Barre Syndrome Treatment Market Drivers
Table 12. Guillain-Barre Syndrome Treatment Market Challenges
Table 13. Guillain-Barre Syndrome Treatment Market Restraints
Table 14. Global Guillain-Barre Syndrome Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Guillain-Barre Syndrome Treatment Market Share by Players (2018-2023)
Table 16. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2022)
Table 17. Ranking of Global Top Guillain-Barre Syndrome Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Guillain-Barre Syndrome Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
Table 21. Date of Enter into Guillain-Barre Syndrome Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Guillain-Barre Syndrome Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Guillain-Barre Syndrome Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. CSL Limited Company Detail
Table 47. CSL Limited Business Overview
Table 48. CSL Limited Guillain-Barre Syndrome Treatment Product
Table 49. CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 50. CSL Limited Recent Development
Table 51. Grifols S A Company Detail
Table 52. Grifols S A Business Overview
Table 53. Grifols S A Guillain-Barre Syndrome Treatment Product
Table 54. Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 55. Grifols S A Recent Development
Table 56. Octapharma AG Company Detail
Table 57. Octapharma AG Business Overview
Table 58. Octapharma AG Guillain-Barre Syndrome Treatment Product
Table 59. Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 60. Octapharma AG Recent Development
Table 61. Kedrion Biopharma Inc Company Detail
Table 62. Kedrion Biopharma Inc Business Overview
Table 63. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Product
Table 64. Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 65. Kedrion Biopharma Inc Recent Development
Table 66. Biotest AG Company Detail
Table 67. Biotest AG Business Overview
Table 68. Biotest AG Guillain-Barre Syndrome Treatment Product
Table 69. Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 70. Biotest AG Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barre Syndrome Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Guillain-Barre Syndrome Treatment Market Share by Type: 2022 VS 2033
Figure 3. Immunoglobulin Therapy Features
Figure 4. Plasma Exchange (Plasmapheresis) Features
Figure 5. Global Guillain-Barre Syndrome Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Guillain-Barre Syndrome Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Guillain-Barre Syndrome Treatment Report Years Considered
Figure 11. Global Guillain-Barre Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Guillain-Barre Syndrome Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Guillain-Barre Syndrome Treatment Market Share by Region: 2022 VS 2033
Figure 14. Global Guillain-Barre Syndrome Treatment Market Share by Players in 2022
Figure 15. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Guillain-Barre Syndrome Treatment Revenue in 2022
Figure 17. North America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Guillain-Barre Syndrome Treatment Market Share by Country (2018-2033)
Figure 19. United States Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Guillain-Barre Syndrome Treatment Market Share by Country (2018-2033)
Figure 23. Germany Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Guillain-Barre Syndrome Treatment Market Share by Region (2018-2033)
Figure 31. China Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Guillain-Barre Syndrome Treatment Market Share by Country (2018-2033)
Figure 39. Mexico Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Guillain-Barre Syndrome Treatment Market Share by Country (2018-2033)
Figure 43. Turkey Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. CSL Limited Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 46. Grifols S A Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 47. Octapharma AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 48. Kedrion Biopharma Inc Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 49. Biotest AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed